Concepedia

Jean-Mehdi Jouniaux

JJ

Statistics

Publications

5

Citations

597

H-Index

5

Active since

2020

Affiliations

Centre National de la Recherche Scientifique(Current)

Institut Gustave Roussy

Université Paris-Saclay

Inserm

Fondazione IRCCS Istituto Nazionale dei Tumori

Jean-Mehdi Jouniaux is an author at Centre National de la Recherche Scientifique specializing in oncology, immunotherapy, and cancer immunology.

Publications per year

2020–2024

5

Publications

5

Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer

Clélia Coutzac, Jean-Mehdi Jouniaux, Angélo Paci et al. · Nature Communications · 2020 · 469 citations · Full text

, , +17

B cells and the coordination of immune checkpoint inhibitor response in patients with solid tumors

Ronan Flippot, Marcus de Melo Teixeira, Macarena Rey-Cárdenas et al. · Journal for ImmunoTherapy of Cancer · 2024 · 37 citations · Full text

, , +17

CD8<sup>+</sup>PD-1<sup>+</sup> to CD4<sup>+</sup>PD-1<sup>+</sup> ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers

Boris Duchemann, Marie Naigeon, Édouard Auclin et al. · Journal for ImmunoTherapy of Cancer · 2022 · 36 citations · Full text

, , +17

Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8 <sup>+</sup> T cells in patients with advanced NSCLC

Marie Naigeon, Matthieu Roulleaux Dugage, François‐Xavier Danlos et al. · Science Advances · 2023 · 35 citations · Full text

, , +17

Overcoming resistance to αPD-1 of MMR-deficient tumors with high tumor-induced neutrophils levels by combination of αCTLA-4 and αPD-1 blockers

Laëtitia Nebot-Bral, Antoine Hollebecque, Andrey A. Yurchenko et al. · Journal for ImmunoTherapy of Cancer · 2022 · 20 citations · Full text

, , +17

1–5 of 5